SFA
TEVA icon

Sequoia Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Sequoia Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.47M Buy
190,940
+21,240
+13% +$707K 0.03% 304
2026
Q1 		$5.11M Buy
169,700
+31,756
+23% +$1.02M 0.03% 321
2025
Q4 		$4.31M Buy
137,944
+1,996
+1% +$49.2K 0.02% 354
2025
Q3 		$2.75M Buy
135,948
+2,655
+2% +$46.6K 0.02% 440
2025
Q2 		$2.23M Buy
133,293
+541
+0.4% +$8.73K 0.02% 442
2025
Q1 		$2.04M Buy
132,752
+18,955
+17% +$339K 0.02% 433
2024
Q4 		$2.51M Buy
113,797
+1,417
+1% +$25.8K 0.02% 363
2024
Q3 		$2.03M Buy
112,380
+805
+0.7% +$14.1K 0.02% 372
2024
Q2 		$1.81M Buy
111,575
+826
+0.7% +$12.7K 0.02% 351
2024
Q1 		$1.56M Buy
110,749
+411
+0.4% +$5.18K 0.02% 376
2023
Q4 		$1.15M Buy
110,338
+5,137
+5% +$48K 0.01% 485
2023
Q3 		$1.07M Buy
105,201
+827
+0.8% +$7.7K 0.02% 319
2023
Q2 		$786K Sell
104,374
-5,839
-5% -$47.3K 0.01% 398
2023
Q1 		$975K Buy
110,213
+7,963
+8% +$78.7K 0.02% 318
2022
Q4 		$933K Buy
+102,250
New +$892K 0.02% 301
2022
Q2 		– Sell
-12,690
Closed -$119K – 678
2022
Q1 		$119K Buy
12,690
+1,713
+16% +$14.3K ﹤0.01% 635
2021
Q4 		$88K Buy
+10,977
New +$99.1K ﹤0.01% 574
2021
Q1 		– Sell
-10,797
Closed -$104K – 466
2020
Q4 		$104K Buy
+10,797
New +$103K ﹤0.01% 406
2020
Q2 		– Sell
-14,025
Closed -$126K – 399
2020
Q1 		$126K Buy
+14,025
New +$144K 0.01% 340

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sequoia Financial Advisors's TEVA Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Teva Pharmaceuticals (TEVA) stake by 13% in Q2 2026, buying an estimated $707K and bringing the position to 190,940 shares worth $6.47M. The position accounts for 0.03% of the portfolio, ranked #304.

Sequoia Financial Advisors first reported a position in TEVA in Q1 2020 and has held it in 19 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sequoia Financial Advisors held 190,940 shares of Teva Pharmaceuticals worth $6.47M as of Q2 2026.
  • Sequoia Financial Advisors bought 21,240 Teva Pharmaceuticals shares in Q2 2026, an estimated $707K.
  • Teva Pharmaceuticals made up 0.03% of Sequoia Financial Advisors's portfolio in Q2 2026, its #304 holding.
  • Sequoia Financial Advisors first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 19 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.